Celularity
2016
FOUNDED
PRIVATE
STATUS
Early Stage VC
LATEST DEAL TYPE
$77.7M
LATEST DEAL AMOUNT
13
INVESTORS
Description
Developer of therapies designed to treat autoimmune and degenerative diseases, immuno-oncology and functional regeneration. The company's therapies productize allogeneic cells and tissues derived from the postpartum placenta and have the ability to augment immunity and longevity by amplifying the body's ability to fight disease, heal and regenerate itself, enabling patients to begin treatment more quickly, resulting in a better medical outcome.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 33 Technology Drive
- Warren, NJ 07059
- United States
+1 (908) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Celularity’s full profile, request a free trial.
Celularity Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 09-Nov-2018 | $77.7M | 00000 | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 15-Feb-2018 | 00000 | 00000 | 00000 | Completed | Generating Revenue |
Celularity Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series X | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Celularity Competitors (56)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CytImmune | Venture Capital-Backed | Rockville, MD | 000.00 | 0000000000 0 | 000.00 | |
| 0000000 0000000000 | Venture Capital-Backed | Indianapolis, IN | 00 | 000.00 | 0000000000 0 | 000.00 |
| 00000000000 | Angel-Backed | Culver City, CA | 00000 | 000000000000 | 00000 | |
| 000000000000 | Venture Capital-Backed | Houston, TX | 000.00 | 00000000000 | 000.00 | |
| 000000 00000000000 | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
Celularity Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 | 31-Aug-2018 | 000000000000000000 | Laboratory Services (Healthcare) | 000000 000000 00.0 | |
| 0000000 0000000000 | 07-May-2018 | 000000000 00000 00 | 0000 | Buildings and Property | 000000 000000 00.0 |
| HLI Cellular Therpaeutics | 31-May-2017 | Merger/Acquisition | Biotechnology |
Celularity Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00000000 | Laboratory Services (Healthcare) | Irvine, CA | 0000 |
Celularity Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Castor Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Green D Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Alumni Ventures Group | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Andrew von Eschenbach | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
| Celgene | Corporation | Minority | 000 0000 | 000000 0 |
Celularity Executive Team (11)
1 Former Executive
You’re viewing 5 of 11 executives. Get the full list »Celularity Board Members (11)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Andrew Pecora MD | Self | Board Member | 000 0000 | |
| Andrew von Eschenbach MD | Self | Board Member | 000 0000 | |
| Bill Maris | Section 32 | Board Member | 000 0000 | |
| David Deming | Self | Board Member | 000 0000 | |
| David Lemus | Self | Board Member | 000 0000 |